Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey


KILIÇKAP S., Demirci U., Bugdayci F., Tural D., Korkmaz T. , PAYDAŞ S., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 14 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.1016/j.jtho.2019.08.1166
  • Title of Journal : JOURNAL OF THORACIC ONCOLOGY
  • Keywords: ALK positive, ROS1 positive, Lorlatinib, Advanced stage lung cancer